ANTIMICROBIAL RESISTANCE: THE SILENT PANDEMIC RESHAPING MODERN MEDICINE

Authors

  • Priyam Singh, Sumaira Ahmed

DOI:

https://doi.org/10.25215/0557983827.09

Abstract

Antimicrobial resistance (AMR) has become one of the gravest threats confronting global health systems today, progressively weakening the pharmacological arsenal that modern clinical practice depends upon. Microbial pathogens spanning bacterial, viral, fungal, and parasitic categories are displaying diminishing susceptibility to agents that previously controlled them reliably. This chapter analyses AMR through three related lenses: the conditions that have accelerated its emergence, the laboratory and field platforms available to characterise resistance, and the therapeutic and governance innovations under development. Central challenges include unconstrained antibiotic consumption in human and veterinary medicine, a shrinking pipeline of novel agents, fragmented resistance monitoring, and the biological machinery enabling rapid inter-species gene transfer. Diagnostic progress ranges from traditional growth-based assays to proteomic identification, molecular gene detection, genomic sequencing, and decentralised rapid testing. Emerging countermeasures include computationally guided drug design, phage-mediated therapy, CRISPR-based precision tools, and host-derived antimicrobial peptides. Addressing AMR effectively will require unified, multi-sectoral effort anchored in evidence and institutional accountability.

Published

2026-07-03